Your browser doesn't support javascript.
loading
Is there an HbA1c Threshold for Symptoms of Chronic Hyperglycemia?
Müller, Nicolle; Lehmann, Thomas; Müller, Ulrich Alfons; Kloos, Christof.
Affiliation
  • Müller N; Department for Internal Medicine III, Jena University Hospital, Jena, Germany.
  • Lehmann T; Jena University Hospital, Center for Clinical Studies, Jena, Germany.
  • Müller UA; Practice for Endocrinology and Diabetology, Dr. Kielstein Ambulante Medizinische Betreuung GmbH, Jena, Germany.
  • Kloos C; Department for Internal Medicine III, Jena University Hospital, Jena, Germany.
Exp Clin Endocrinol Diabetes ; 130(6): 386-392, 2022 Jun.
Article in En | MEDLINE | ID: mdl-34100271
ABSTRACT
AIMS OF THE STUDY The minimum therapeutic goal regarding metabolic control for people with diabetes mellitus is the "absence of symptoms of hyperglycemia." However, it is uncertain whether a level of HbA1c can be defined that guarantees the absence of these symptoms. The aim was to define an HbA1c threshold above which most patients show hyperglycemic symptoms.

METHODS:

In a multicenter cross-sectional study, 137 patients with type 1 and 285 with type 2 diabetes were asked about their symptoms during periods of hyperglycemia with a standardized questionnaire. Seventeen symptoms of hyperglycemia were summarized to the total hyperglycemia symptom score (THSS; min. 0; max. 68). The answers could be given according to the frequency and intensity in the last 4 - 6 weeks.

RESULTS:

The HbA1c threshold above which most patients showed hyperglycemic symptoms was 10.05% for patients with diabetes type 1 and 8.9%. for patients with type 2. Most confidence was reached on the symptoms of frequent urination" and "tiredness." The mean THSS was 19.4 (±9.0) and showed a positive correlation with age (r=0.167; p<0.001) and HbA1c (r=0.254; p<0.001).

CONCLUSIONS:

We identified an HbA1c threshold above which most patients show symptoms of hyperglycemia. In the treatment of people with diabetes mellitus, a safety margin to this threshold should be maintained to preserve well-being and avoid distress. However, since hyperglycemia symptoms are subject to many influencing factors, an adjustment of the therapy-both intensification and de-intensification-should always be carried out in combination with the requested hyperglycemia symptoms and HbA1c value.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Hyperglycemia Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Exp Clin Endocrinol Diabetes Journal subject: ENDOCRINOLOGIA Year: 2022 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Hyperglycemia Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Exp Clin Endocrinol Diabetes Journal subject: ENDOCRINOLOGIA Year: 2022 Document type: Article Affiliation country: Germany